Press Releases

Date	Title	Company
31-Jul-2023	Camzyos®▼(mavacamten) granted Marketing Authorisation in Great Britain for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)	BMS
31-Jul-2023	MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group	MediClin AG
31-Jul-2023	Coriolis Pharma and RheaVita Join Forces in Collaboration for Continuous and Controlled Freeze-Drying Technology	B3C newswire
30-Jul-2023	IGEA Pharma N.V.: IGEA discloses its Annual Report 2022	IGEA Pharma N.V.
29-Jul-2023	Alfa Chemistry Announces Exciting Launch of Cosmetic Ingredients and Beauty Peptides	Alfa Chemistry
28-Jul-2023	Glycopeptide antibiotics Market Revenue to Hit the US$6.6 Billion by 2030	The Wire Times
28-Jul-2023	Clinical Communication Software Market Primed for a Remarkable Expansion of 3.58 Billion by 2029	The Wire Times
28-Jul-2023	Computer Assisted Coding Market Poised for Remarkable Growth, projected to Hit US$ 13.08 Billion by 2030	The Wire Times
28-Jul-2023	Acute Spinal Cord Injury Market is Expected to Reach the Valuation of USD 9,892.5 Million by 2030	The Wire Times
28-Jul-2023	Fractional Laser Market to Reach $3.0 Billion by the End of 2030	The Wire Times
28-Jul-2023	Healthcare Information Technology (IT) Market Size Poised to Hit USD 1319.28 Billion and Grow at a CAGR of 16.8% by 2030	The Wire Times
28-Jul-2023	Myxoma Market to Witness Impressive Growth Potential of 6.50% by 2029	The Wire Times
28-Jul-2023	Disposable Incontinence Products Market Size Worth USD 15.89 Billion by 2030	The Wire Times
28-Jul-2023	Pediatric Home Healthcare Market Geared for Substantial Growth Rate of 7.8% by 2029	The Wire Times
28-Jul-2023	Electroporation Instruments Market is Projected a Momentous Growth of USD 1,447.80 Million by 2029	The Wire Times
28-Jul-2023	IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center	IO Biotech
28-Jul-2023	OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center	OKYO Pharma
28-Jul-2023	GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030	GILEAD
28-Jul-2023	Approval of the combination of Envirotainer and va-Q-tec´s pharma offering - to establish a complete portfolio of unrivalled temperature-controlled solutions	Envirotainer
28-Jul-2023	What nap times reveal about your child’s brain development	University of East Anglia